|
DFTX Definium Therapeutics Inc 1813814 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-77,098,000.00 |
| Balance Sheet |
|
Current Assets
|
$380,563,000.00 |
|
Assets
|
$401,293,000.00 |
|
Current Liabilities
|
$81,112,000.00 |
|
Liabilities
|
$122,444,000.00 |
|
Equity
|
$278,849,000.00 |
|
Shares Out
|
104044508.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-42,631,000.00 |
|
Investing Cash Flow
|
$42,000,000.00 |
| Market Analysis |
Market Cap
|
$4,628,940,160.92 |
|
Price
|
$42.21 |
|
BVPS
|
2.68 |
|
PB
|
16.60 |
|
EPS
|
-0.71 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:21 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:17 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-2.06 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
-0.71 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view DFTX documents filed with the SEC.
DFTX Filings
Clear
